FOLR1 and cancer: For this reason, FRα has been viewed as a potential marker for both folic acid and FRα specific antibodies (Abs) to develop a diagnostic and targeted drug delivery system for discriminating between normal cells and FRα-overexpressing cancer cells (Ab et al., 2015; Sato & Itamochi, 2016).